Dyadic International (NASDAQ:DYAI) Announces Earnings Results

by · The Cerbat Gem

Dyadic International (NASDAQ:DYAI – Get Free Report) announced its quarterly earnings results on Tuesday. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.06, Zacks reports. The company had revenue of $1.96 million during the quarter, compared to the consensus estimate of $1.05 million. Dyadic International had a negative return on equity of 140.01% and a negative net margin of 188.09%. During the same period in the previous year, the business earned ($0.06) EPS.

Dyadic International Stock Performance

Shares of DYAI stock traded down $0.02 during mid-day trading on Wednesday, hitting $1.12. 22,804 shares of the stock were exchanged, compared to its average volume of 47,767. The stock’s fifty day simple moving average is $1.13 and its two-hundred day simple moving average is $1.42. The company has a debt-to-equity ratio of 1.72, a quick ratio of 5.39 and a current ratio of 5.39. Dyadic International has a 12-month low of $0.93 and a 12-month high of $2.67.

Dyadic International Company Profile

(Get Free Report)

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.

Recommended Stories